Search

everythinglearnresearchcommunity

for

Search:↓

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

New treatments for male hypogonadism are effective and should be personalized.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Hair loss in women linked to higher sexual dysfunction risk.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Pharmacists play a crucial role in patient education and personalized care.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The ketogenic diet may help manage PCOS symptoms but needs more research for long-term effects.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hair loss linked to higher heart disease risk in both men and women.